Ocular Surface Disease

Healio compiled the most-read news in allergy, asthma and immunology posted in February.

Patients with atopic dermatitis and moderate to severe ocular surface disease who were treated with dupilumab had higher levels of the biologic in their tears than those with mild or no ocular surface disease, according to study results.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

The success of ocular surgery, especially refractive surgery, hinges on the health of the ocular surface.

TC-002, a latanoprost ophthalmic solution, met all primary and secondary endpoints in the phase 3 CLEAR pivotal trial, according to a press release from TearClear.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Adam Szaronos, CEO of TearLab, discusses the intersection of ocular surface disease treatment and refractive cataract surgery.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses some of the factors, including cosmetics and lifestyle, that contribute to ocular surface disease.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses a case of dupilumab-induced ocular surface disease and management strategies.

WAIKOLOA, Hawaii — Preeya K. Gupta, MD, founder and director of Triangle Eye Consultants in Durham, North Carolina, discussed ocular surface disease at Hawaiian Eye 2022.

WAIKOLOA, Hawaii — Diagnosing and treating ocular surface disease preoperatively is one of the elements that contribute to elevated patient satisfaction postoperatively, Marjan Farid, MD, said at Hawaiian Eye 2022.